Innovative Device Reconstructs Gastroesophageal Reflux Barrier
|
By HospiMedica International staff writers Posted on 02 Jan 2018 |

Image: The EsophyX Z+ device with close up of tissue mold (Photo courtesy of EndoGastric Solutions).
A novel transoral endoscopic system enables physicians to rebuild the gastroesophageal valve (GEV) with a partial fundoplication technique.
The EndoGastric Solutions (Redmond, WA, USA) EsophyX Z+ device offers patients who need to undergo an anatomical repair of the GEV an effective treatment option to correct severe gastroesophageal reflux disease (GERD). The device enables the creation of a 2-3 cm, 270° esophagogastric fundoplication, using the transoral incisionless fundoplication (TIF) technique. A flexible video endoscope is first inserted into the central lumen of the EsophyX device to provide direct visualization throughout the TIF procedure.
A helical retractor is then used to retract tissue and anchor the gastroesophageal junction during the fundoplication. It then stows away safely inside the tissue mold during insertion and removal. The next stage involves the Tissue Mold and Chassis, which plicates and compresses the tissue and rotates the fundus around esophagus to create a partial wrap. An Invaginator then suctions the tissue to reduce the small hiatal hernia, facilitating positioning of the fundoplication caudal to the diaphragm. Finally, stylets and SerosaFuse fasteners are used to transect the apposed tissues and maintain tissue compression throughout the healing process.
“We are excited to launch the EsophyX Z+ device, as we believe it will further enhance the physician’s technical experience,” said Skip Baldino, President and CEO of EndoGastric Solutions. “At EndoGastric Solutions, we are committed to addressing the unmet needs in gastrointestinal diseases and offering physicians highly effective options that fill the significant treatment gap between medication and more invasive surgery.”
“GERD is a chronic condition, and proton pump inhibitors do not control symptoms in about one-third of patients,” said surgeon Michael Murray, MD, of Northern Nevada Medical Center (Sparks, NV, USA). “The design of the new EsophyX Z+ device makes performing TIF 2.0 procedures technically easy, and produces a consistent and effective fundoplication, providing an effective alternative to prescription medications and traditional surgical procedures.”
GERD is a chronic condition in which the GEV allows gastric contents to reflux into the esophagus, causing heartburn and possible injury to the esophageal lining. In most GERD patients, the esophageal sphincter is weakened and does not close tightly, allowing digestive juices to return and irritate the esophageal lining. Fundoplication, which involves folding and reinforcing the annulus between the esophagus and the stomach by wrapping the upper portion of the stomach around the lowest portion of the esophagus, can help restore the compromised reflux barrier.
Related Links:
EndoGastric Solutions
The EndoGastric Solutions (Redmond, WA, USA) EsophyX Z+ device offers patients who need to undergo an anatomical repair of the GEV an effective treatment option to correct severe gastroesophageal reflux disease (GERD). The device enables the creation of a 2-3 cm, 270° esophagogastric fundoplication, using the transoral incisionless fundoplication (TIF) technique. A flexible video endoscope is first inserted into the central lumen of the EsophyX device to provide direct visualization throughout the TIF procedure.
A helical retractor is then used to retract tissue and anchor the gastroesophageal junction during the fundoplication. It then stows away safely inside the tissue mold during insertion and removal. The next stage involves the Tissue Mold and Chassis, which plicates and compresses the tissue and rotates the fundus around esophagus to create a partial wrap. An Invaginator then suctions the tissue to reduce the small hiatal hernia, facilitating positioning of the fundoplication caudal to the diaphragm. Finally, stylets and SerosaFuse fasteners are used to transect the apposed tissues and maintain tissue compression throughout the healing process.
“We are excited to launch the EsophyX Z+ device, as we believe it will further enhance the physician’s technical experience,” said Skip Baldino, President and CEO of EndoGastric Solutions. “At EndoGastric Solutions, we are committed to addressing the unmet needs in gastrointestinal diseases and offering physicians highly effective options that fill the significant treatment gap between medication and more invasive surgery.”
“GERD is a chronic condition, and proton pump inhibitors do not control symptoms in about one-third of patients,” said surgeon Michael Murray, MD, of Northern Nevada Medical Center (Sparks, NV, USA). “The design of the new EsophyX Z+ device makes performing TIF 2.0 procedures technically easy, and produces a consistent and effective fundoplication, providing an effective alternative to prescription medications and traditional surgical procedures.”
GERD is a chronic condition in which the GEV allows gastric contents to reflux into the esophagus, causing heartburn and possible injury to the esophageal lining. In most GERD patients, the esophageal sphincter is weakened and does not close tightly, allowing digestive juices to return and irritate the esophageal lining. Fundoplication, which involves folding and reinforcing the annulus between the esophagus and the stomach by wrapping the upper portion of the stomach around the lowest portion of the esophagus, can help restore the compromised reflux barrier.
Related Links:
EndoGastric Solutions
Latest Surgical Techniques News
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







